Literature DB >> 20460017

Cell-based therapy - navigating troubled waters.

Michael S Pepper1.   

Abstract

Cells and engineered tissue can be used to treat an increasing number of diseases. This development, together with promising pre-clinical data in regenerative medicine, has raised the expectations of many patients. However, this situation tends to make people vulnerable to the lures of companies that abuse the stem cell promise. The problem is compounded by people's propensity to believe that the healing powers of positive thinking, large sums of money and foreign institutions are greater than those of therapies developed through well-tested, properly constructed, clinical trials.

Entities:  

Mesh:

Year:  2010        PMID: 20460017     DOI: 10.7196/samj.4131

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

Review 1.  Stem cells in clinical practice: applications and warnings.

Authors:  Daniele Lodi; Tommaso Iannitti; Beniamino Palmieri
Journal:  J Exp Clin Cancer Res       Date:  2011-01-17

2.  Heterologous mesenchymal stem cells successfully treat femoral pseudarthrosis in rats.

Authors:  Manoel Luiz Ferreira; Paulo Cesar Silva; Lucas Henrique Alvarez Silva; Danielle Cabral Bonfim; Lucas Cristo Conilho Macedo Müller; Christiano Costa Espósito; Alberto Schanaider
Journal:  J Transl Med       Date:  2012-03-20       Impact factor: 5.531

Review 3.  Opportunities and barriers to establishing a cell therapy programme in South Africa.

Authors:  Carlo Stephan Jackson; Michael S Pepper
Journal:  Stem Cell Res Ther       Date:  2013-05-29       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.